Oct 26, 2023 / 06:00AM GMT
Klas Palin - Erik Penser Bank - Analyst
Good morning, everyone. Welcome to Erik Penser Bank, this morning's slide presentation of the nine months interim report of Senzime. And here to present the nine month report is CEO, Philip Siberg, very welcome.
Philip Siberg - Senzime AB(publ)-CEO
Good morning.
Klas Palin - Erik Penser Bank - Analyst
Go ahead with your presentation, please.
Philip Siberg - Senzime AB(publ)-CEO
All right. Thank you, thank you very much. I'm here to kind of give the highlights of the Q3 report that we just published this morning here in Sweden.
So Senzime, just a brief recap. We are a Swedish headquartered medical device company. We're in the midst of a technology and clinical shift where we are providing monitoring solutions to help eliminate complications as a result of anesthesia and also as a result of opioids and other medications as you're in the perioperative mode of
Q3 2023 Senzime AB (publ) Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
